The Association of Cancer Care Centers has spent years working for greater diversity in clinical trials. ACCC members will bring concerns to Congress ahead of their annual business meeting in Washington, DC.
Planners of this week’s meeting of Association of Cancer Care Centers (ACCC) knew what they were doing when they selected Nick Webb, author of the book Chaotic Change: Embracing Chaos to Drive Innovation and Growth, to kick off the 51st Annual Meeting & Cancer Center Business Summit, which runs Wednesday through Friday.
Nadine Barrett, PhD, MS, MPH, FACCC | Image: Wake Forest
Held each year in the nation’s capital, attendees will be within walking distance of the White House as they arrive at the Capital Hilton tonight, just as President Donald J. Trump gets ready for the first State of the Union address of his second term; the meeting will conclude midday Friday as the “Stand Up for Science” rally forms nearby on the National Mall.
After 6 weeks of upheaval at the agencies most connected to cancer care, ACCC members will bring many concerns to members of Congress when they make their annual visit to Capitol Hill Wednesday morning. ACCC’s longtime commitment to improving health equity and diversity in clinical trials is directly affected by the Trump executive order rolling back diversity, equity, and inclusion (DEI) initiatives.
The honoree for the ACCC clinical research award, Mandi-Pratt Chapman, PhD, was featured in Science following a loss of funding from the National Institutes of Health due to the DEI order. Pratt-Chapman, who is the associate center director, Patient-Centered Initiatives and Health Equity at GW Cancer Center, is well-known for her work on appropriate ways to collect information on sexual orientation and gender identity of cancer patients.
Wednesday’s poster presentations will include 3 projects related to addressing disparities and improving clinical trial inclusivity:
At its opening reception, ACCC will honor longtime Executive Director Christian Downs, JD, MHA, who is now a senior consultant, with its annual achievement award.
Thursday’s sessions kick off with a question and answer session with ACCC President Nadine Barrett, PhD, MS, MPH, FACCC, who is senior associate dean, Community Engagement and Equity in Research at Wake Forest University School of Medicine and Atrium Health. Joining Barrett will be Robin Zon, MD, FASCO, FACP, president of the American Society of Clinical Oncology and physician emeritus, Michiana Hematology Oncology.
ACCC is structured around “deep dives” which are 2-hour intensives on the meeting’s core topics of technology, business, and policy. Thursday’s deep dives include sessions on artificial intelligence to streamline processes and increase clinical trial enrollment, using technology to manage workflow in radiation oncology, and use of various types of virtual visits with to increase access, speed referrals, and boost revenue. Payer issues are featured in an afternoon deep dive that will examine payer contract intelligence, creating a prior authorization team, and using providers as boots on the ground to change policy at the state level.
Other deep dives include sessions on community engagement, improving clinical trials, and implementing new technology. Thursday’s schedule also includes a policy update with an HHS official, but thus far the department has not sent promised representatives to other health care conferences since Trump took office. On Friday, cancer center leaders will offer firsthand accounts of growth strategies in their respective markets; the meeting will conclude with a session on the growth of women’s health and oncology.
Safety and Efficacy Updates for Asthma and Urticaria Therapies
April 5th 2025The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and favorable hematological safety profile of remibrutinib, were highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Pharmacy Deserts, Biosimilars, and Market Trends Are Shaping Managed Care
April 2nd 2025Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in managed care, creating both challenges and opportunities for stakeholders, as explored by speakers at the Academy of Managed Care Pharmacy’s annual meeting.
Read More
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More